• Medifast Inc MED.N, MED is expected to show a fall in quarterly revenue when it reports results on November 3 for the period ending September 30 2025

• The Baltimore Maryland-based company is expected to report a 40.0% decrease in revenue to $84.1 million from $140.16 million a year ago, according to the estimate from one analyst, based on LSEG data.The company's guidance on August 4 2025, for the period ended September 30, was for revenue between $70.00 million and $90.00 million.

• ​LSEG's mean analyst estimate for Medifast Inc is for a loss of 39 cents per share. The company's EPS guidance on August 4 2025, for the period ended September 30, was between $-0.60 and $0.00

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Medifast Inc is $15.00, about 19.9% above its last closing price of $12.02

This summary was machine generated October 31 at 23:43 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)